norethindrone

Key facts

INN

norethindrone

Brand

NOR-QD

Route

ORAL-28

Formulation

TABLET

Originator

Amneal Pharmaceuticals

Related patents

patent

US 12428487

Complexes comprising an anti-transferrin receptor antibody linked to an oligonic

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12370264

Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12329825

Muscle targeting complexes comprising an anti-transferrin receptor antibody link

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12325753

Method of using an anti-transferrin receptor antibody to deliver an oligonucleot

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12319743

Complexes comprising an anti-transferrin receptor antibody linked to an oligonuc

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12263225

Muscle-targeting complexes comprising an anti-transferrin receptor antibody link

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12214021

Study on lactoferrin regulation of bone formation by means of vitamin D receptor

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12215320

Compositions and methods for gene editing by targeting transferrin

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is norethindrone?

norethindrone (NOR-QD), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for norethindrone?

NOR-QD is a marketed brand name for norethindrone. Check FDA Drugs@FDA for the current US label holder.